glp-1 obesity drug news today september 29 2025 Alarming rise in weight loss overdoses New GLP-1 Pill Foundayo (Orforglipron)
Pay in 4 interest-free payments of $6.81 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 2 - Aug 7
Live Spec
New GLP 1 Pill Foundayo (Orforglipron) Gets FDA Approval for Obesity GLP 1 receptor agonists are increasingly used to treat type 2 diabetes and obesity, and trials have shown reductions in cardiovascular risk and slowing of kidney failure. Adverse events are mostly gastrointestinal. Read The FDA has approved a new higher dose (7.2 mg) of Wegovy (semaglutide) injection, Wegovy HD, for weight loss and long term weight maintenance in certain adult patientsin just 54 days from filing. GLP 1s and Obesity Coverage: Differing Perspectives for Employers and Health Plans Pharmaceutical Strategies Group (PSG) GLP 1 medications like Ozempic, Wegovy and Mounjaro are changing diabetes and weight management, but they aren't recommended during pregnancy or while nursing. The current recommendation is to stop before conception and discuss Nutritional priorities to support GLP 1 therapy for obesity: A joint advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and the Obesity Society
Store: clickpoint.com.au · Domain: clickpoint.com.au








.png)







.png)









